Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders

NCT01758042 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01758042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
July 31, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all), acute myeloid leukemia (aml), al amyloidosis, aplastic anemia, autoimmune diseases, chronic kidney disease, chronic lymphocytic leukemia (cll), chronic myelogenous leukemia (cml), diamond blackfan anemia, hodgkin disease, multiple myeloma, myelodysplastic syndrome (mds), myelofibrosis, myeloproliferative disease, non-hodgkin's lymphoma (nhl), sickle cell anemia, thalassemia